Search Press releases Keywords From To 31 May 2024 Acquisition of own shares Read More 31 May 2024 UCB announces positive CHMP opinion for 320 mg device presentations of BIMZELX[®]▼ (bimekizumab) Read More 24 May 2024 Acquisition of own shares Read More 23 May 2024 UCB announces publication in The Lancet of phase 3 bimekizumab▼ trials in moderate to severe hidradenitis suppurativa Read More 17 May 2024 Transparency notification Wellington Read More 17 May 2024 Acquisition of own shares Read More Pagination First page Previous page Previous … Page 20 Page 21 Page 22 Page 23 Current page 24 Page 25 Page 26 Page 27 Page 28 … Page 24 of 65 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
